Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.
Oh IJ, Hur JY, Park CK, Kim YC, Kim SJ, Lee MK, Kim HJ, Lee KY, Lee JC, Choi CM.
Oh IJ, et al. Among authors: kim hj, kim sj, kim yc.
Clin Lung Cancer. 2018 Sep;19(5):e775-e781. doi: 10.1016/j.cllc.2018.05.018. Epub 2018 Jun 5.
Clin Lung Cancer. 2018.
PMID: 30149884